BRAIN Biotech AG
BRAIN Biotech AG (XETRA: BNN) is trading at €2.79, about ₹305 at today's EUR/INR rate, as of 25 Sep 2026, 11:35 AM ET, down 0.71% today. Indian residents can buy BRAIN Biotech from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€2.72
Today's high
€2.89
52 week low
€2.05
52 week high
€3.89
BNN opened at €2.89, closed previously at €2.81, and has traded between €2.05 and €3.89 over the past 52 weeks.
About
Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG (renamed from B.R.A.I.N. Biotechnology Research and Information Network AG in April 2021) specializes in the discovery, development, production, and commercialization of advanced biological solutions. These include enzymes, biocatalysts, microorganisms, and naturally derived active compounds, catering to the chemical industry across Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two distinct segments: BioScience and BioIndustrial. The BioScience division is dedicated to uncovering and developing bioactive natural ingredients, such as sugar alternatives, taste modifiers, and other nature-based active components for diverse applications in the food, animal nutrition, skincare, cosmetics, and broader chemical sectors. Concurrently, the BioIndustrial segment focuses on identifying and optimizing enzymes and biocatalysts critical for manufacturing food and beverages, medical wound care products, lubricants, as well as for starch processing and bioethanol production. This segment also engineers microorganisms to serve as functional biomass for optimizing industrial manufacturing processes, converting greenhouse gas CO2 into a valuable industrial raw material, and facilitating the extraction of precious and rare earth metals. Furthermore, BRAIN Biotech AG has established strategic alliances with AnalytiCon Discovery GmbH and Roquette to jointly develop natural sweeteners and enhanced sweet taste solutions.
Key statistics
Avg. volume
4.20K
Market cap
€60.95M
P/E Ratio
-4.23
Price-to-sales ratio
1.03
Enterprise value
€60.01M
Free cash flow yield
-14.56%
Debt-to-equity ratio
0.00
Return on equity
590.52%
ROIC
-21.42%
Beta
0.62
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
€49.62M
Earnings per share
-€0.54
Free cash flow
-€10.76M
Net profit margin
-24.70%
Gross margin
15.94%
EBITDA
-€4.17M
Revenue growth
-9.17%
Similar securities
This is not an investment recommendation
How to buy BRAIN Biotech from India
Indian residents can buy BRAIN Biotech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for BRAIN Biotech and place an order
Find BRAIN Biotech by name or by its ticker, BNN, and choose an order type. BRAIN Biotech trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your BRAIN Biotech position in EUR and INR. BRAIN Biotech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in BRAIN Biotech from India
Trading and taxes when buying BRAIN Biotech from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneBRAIN Biotech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy BRAIN Biotech stock?
Yes. BRAIN Biotech (BNN) has been listed on XETRA since 2016, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one BRAIN Biotech share cost in rupees?
One BRAIN Biotech share is €2.79 — about ₹305 at an EUR/INR rate of 109.26 on 27 Sep 2026. Both the BRAIN Biotech price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying BRAIN Biotech from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on BRAIN Biotech shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the BRAIN Biotech price. Paasa issues a capital-gains statement for your return.
Does BRAIN Biotech pay a dividend?
No. BRAIN Biotech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade BRAIN Biotech from India?
XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.
Do I have to declare BRAIN Biotech shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your BRAIN Biotech holding, its cost and its closing value.
How do I sell BRAIN Biotech and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on BRAIN Biotech?
Yes. BRAIN Biotech is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.